Novel LED Sleep Mask "Ready for Large Clinical Trials” in Diabetic Macular Edema Patients

Article

In most eyes, the mask reduced or resolved cysts in the OCT subfield.

Preliminary findings indicate that wearing a novel sleep mask containing light-emitting diodes (LEDs) may help to reduce retinal thickness in patients with diabetic macular edema (DME). A team led by J.N. Sahni, MD, of St. Paul’s Eye Unit, Royal Liverpool University Hospitals NHS Trust made the conclusion after evaluating the mask in 60 study participants.

The study compared the effect of the mask in a DME group with that in two groups of healthy volunteers, one group age 18—30 years, and another age 50–70 years. Participants wore the mask, which has a luminance of 80 cd/m2 and a wavelength of 504 nm, every night for eight hours or fewer for three months. The study also included a one-month recovery period after three months of active use.

In addition to measuring change from baseline retinal thickness with optical coherence tomography (OCT), the Liverpool team also measured change from baseline values in depression, psychological well-being, sleep, and visual acuity as well as in the number of lapses and response time required for psychomotor vigilance tasks.

The researchers found that, after three months of mask use, 67% of DME-affected eyes had a reduction or resolution of cysts in the OCT subfield with maximal pathology. They also noted that, by study end, thinning was greater in those with greater baseline retinal thickness than in those with less baseline retinal thickness (P < 0.001 for central subfield; P < 0.05 for maximal).

However, sleep disturbances and an inability to tolerate the mask led to study withdrawal in eight participants, or 13%, during the first month of the study, and in 16 participants, or 27%, during the first three months of the study. Nevertheless, the team concluded that use of the mask was acceptable for most study participants except for some healthy volunteers.

Moreover, after three months of using the mask, psychomotor vigilance task performance worsened in the group of healthy younger volunteers, and mean psychological well-being worsened in all study groups. However, the researchers reported that their study revealed no major safety issues associated with use of the mask apart from a minor reduction in daytime alertness and a moderate effect on psychological well-being.

“Preliminary data suggest a beneficial effect on retinal thickness in DMO,” the team concluded, so “This novel therapeutic approach is ready for large clinical trials.”

The published report of the study, “Safety and acceptability of an organic light-emitting diode sleep mask as a potential therapy for retinal disease,” appears in the January 2017, issue of Eye.

Related Coverage:

Diabetic Macular Edema Study: Ozurdex Outperformed Avastin, but Not Without Drawbacks

Explaining Treatment a Key Part of Helping Manage Diabetic Macular Edema

Aflibercept a ‘Powerful Tool’ in Treatment of Diabetic Macular Edema: Charles Wykoff, Retinal Consultants Houston

Related Videos
Cindy X. Cai, MD: Impact of Race, Neighborhood on Diabetic Retinopathy Care | Image Credit: Johns Hopkins University
Dimitra Skondra, MD, PhD: Protective Effect of Metformin in Geographic Atrophy| Image Credit: University of Chicago
Deepak Sambhara, MD | Image Credit: American Society of Retina Specialists
Sean Adrean, MD: Impact of Baseline VA on Aflibercept 8 mg Outcomes in DME | Image Credit: Linkedin
Mark Barakat, MD: Stable IOP Outcomes After Aflibercept 8 mg in DME | Image Credit: Retina Macula Institute of Arizona
Roger Goldberg, MD: Impact of Dual Inhibition on Hard Exudates in DME | Image Credit: Bay Area Retina Associates
Deepayan Kar, PhD, MS: A Virtual Reality Approach to Contrast Sensitivity in AMD | Image Credit: LinkedIn
Dolly Chang, MD, PhD | Image Credit: LinkedIn
Daniel Su, MD: | Image Credit: Retina Vitreous-Associates Medical Group
Daniela Ferrara, MD, PhD: Machine Learning Predicts Functional Outcomes in DME | Image Credit: Ophthalmology Innovation Summit
© 2024 MJH Life Sciences

All rights reserved.